Category: Top Story
-
INOVIO Shares Drop 10% After Discounted $25 Million Public Offering
INOVIO Pharmaceuticals Inc. (NASDAQ:INO) shares fell 10% in early trading after the biotech company announced the pricing of a $25 million underwritten public offering at $1.90 per share, a discount compared to Monday’s closing price of $2.15. The offering includes 13,158,000 shares of common stock, all of which will be sold by INOVIO. The company…
-
Constellation Energy Among Top Utilities Set to Benefit from U.S. Nuclear Expansion, Says BofA
Constellation Energy (NASDAQ:CEG) and several major U.S. utilities are expected to be key beneficiaries of a new federal initiative to accelerate nuclear power development, according to analysts at BofA Securities. The U.S. government recently announced a strategic partnership with Westinghouse and Cameco aimed at building a new wave of nuclear generation facilities. Early reports indicate…
-
Endava Shares Plunge Over 14% After Weak Q1 Results and Soft Guidance
Endava plc (NYSE:DAVA) shares sank more than 14% in premarket trading Tuesday after the IT services and digital transformation company posted disappointing fiscal first-quarter 2026 results and issued a downbeat outlook for the rest of the year. The company reported earnings of £0.15 per share, missing analyst expectations of £0.18, while revenue came in at…
-
enGene Shares Gain 5% After Bladder Cancer Therapy Shows Stronger Response Rates
enGene Holdings Inc. (NASDAQ:ENGN) shares climbed 5% on Tuesday after the clinical-stage genetic medicines company reported promising new data showing improved complete response rates for its investigational bladder cancer treatment detalimogene voraplasmid. The company said that detalimogene achieved a 62% complete response rate at six months in patients with high-risk, BCG-unresponsive non-muscle invasive bladder cancer…
-
Surmodics Shares Skyrocket 50% After Court Rejects FTC Request to Block GTCR Acquisition
Surmodics Inc. (NASDAQ:SRDX) shares soared 50% on Tuesday after a U.S. District Court denied the Federal Trade Commission’s (FTC) motion for a preliminary injunction that sought to halt the company’s pending acquisition by GTCR LLC. The ruling from the Northern District of Illinois removes a major obstacle to the merger, though the deal remains subject…
-
Soleno Therapeutics Shares Jump 8% Following $100 Million Accelerated Buyback Plan
Soleno Therapeutics (NASDAQ:SLNO) shares surged 8% on Tuesday after the biopharmaceutical company announced a $100 million accelerated share repurchase (ASR) agreement with Jefferies LLC, underscoring confidence in its financial outlook and growth prospects. The Board of Directors approved the buyback program, which includes an initial delivery of approximately 1,511,553 shares, based on Soleno’s closing price…
-
Neuphoria Shares Climb 4% After Launching Strategic Review to Enhance Shareholder Value
Neuphoria Therapeutics (NASDAQ:NEUP) shares gained 4% on Tuesday after the clinical-stage biotechnology firm announced the initiation of a strategic review aimed at maximizing shareholder value. The company, which specializes in developing therapies for neuropsychiatric disorders, said it is evaluating a range of potential options — including mergers, acquisitions, partnerships, joint ventures, and licensing agreements. To…
-
EnviroStar Shares Tick Higher as Record Revenue Balances EPS Miss
EnviroStar Inc. (AMEX:EVI) shares edged up 1.7% in premarket trading on Tuesday after the company posted record first-quarter revenue, which narrowly missed analyst forecasts, while earnings came in below expectations due to higher spending on technology and integration initiatives. The commercial laundry equipment distributor reported adjusted earnings of $0.11 per share, short of the $0.15…
-
AngloGold Ashanti Shares Gain Nearly 3% as Profits Surge on Soaring Gold Prices
AngloGold Ashanti plc (NYSE:AU) saw its shares climb 2.7% in premarket trading on Tuesday after the gold miner posted a record-breaking third quarter, driven by higher gold prices and strong cost management. The company reported free cash flow of $920 million, up 141% year-on-year, while headline earnings jumped to $672 million, or $1.32 per share,…
-
Sea Shares Slide Over 5% as Earnings Miss Overshadows Strong Revenue Growth
Sea Limited (NYSE:SE) shares tumbled more than 5% in premarket trading on Tuesday after the Southeast Asian technology conglomerate reported third-quarter 2025 earnings that missed forecasts, despite strong revenue expansion across all its business divisions. The company posted adjusted earnings of $0.59 per share, falling short of analysts’ expectations of $1.02 per share by 43…